Low plasma levels of dehydroepiandrosterone sulphate in HIV-positive patients coinfected with Hepatitis C virus

HIV Medicine

Volumn 5, Issue 3, 2004, Pages 151-157

  Mauboussin, J M ^a   Mahamat, A ^b,c   Peyriere H ^a,d   Rouanet, I ^a   FAbbro Peray, P ^b,c   Daures, J P ^b,c   Vincent, Denis ^a  

^a DEPARTMENT OF NEUROLOGY   (France)

^b Pneumology Department Internal Medicine A Gaston Doumergue Hospital   (France)

^c UNIV MONTPELLIER   (France)

^d LAPEYRONIE HOSPITAL   (France)

Author keywords

Coinfection; Dehydroepiandrosterone levels; Gender; Hepatitis C virus; HIV

Indexed keywords

ANTIRETROVIRUS AGENT; HEPATITIS C ANTIBODY; PRASTERONE SULFATE; VIRUS RNA;

ADULT; AGE DISTRIBUTION; ANALYSIS OF VARIANCE; ANDROGEN BLOOD LEVEL; ARTICLE; CLINICAL EXAMINATION; COHORT ANALYSIS; COMORBIDITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; DEMOGRAPHY; FEMALE; FRANCE; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OUTPATIENT CARE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; SEX DIFFERENCE; SOCIAL ASPECT; UNIVERSITY HOSPITAL; VIROLOGY;

EID: 2942650290     PISSN: 14642662     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1468-1293.2004.00203.x     Document Type: Article

References (21)

1. Ebeling P, Koivisto V. Physiologic importance of dehydroepiandrosterone. Lancet 1994; 343: 1479-1481.
2. Orentreich N, Brind JL, Rizer RL, Vogelman JH. Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations througthout adulthood. J Clin Endocrinol Metab 1984; 59: 551-555.
3. Zumoff B, Rosenfeld RS, Strain GW, Levin J, Fukushima DK. Sex differences in the twenty-four-hour mean plasma concentrations of dehydroisoandrosterone (DHA) and dehydroisoandrosterone sulfate (DHAS) and the DHA to DHAS ratio in normal adults. J Clin Endocrinol Metab 1980; 51: 330-333.
4. Merrill CR, Harrison MG, Sunderland T. Plasma dehydroepiandrosterone levels in HIV infection. J Am Med Assoc 1989; 261: 1149.
5. Piketty C, Jayle D, Gonzalez-Canali G, Debuire B, Baulieu EE, Kazatchkine MD. Low plasma levels of dehydroepiandosterone (DHEA) and incidence of lipodystrophy. HIV Med 2001; 2: 136-138.
6. Christeff N, de Truchis P, Melchior JC, Perronne C, Gougeon ML. Longitudinal evolution of HIV-1-associated lipodystrophy is correlated to serum cortisol: DHEA ratio and IFN-α. Eur J Clin Invest 2002; 32: 775-784.
7. Thomas DL. Hepatitis C and human immunodeficiency virus infection. Hepatology 2002; 36 (Suppl. 5): S201-S209.
8. McDonald JA, Handelsman DJ, Dilworth P, Conway AJ, McCaughan GW. Hypothalamic-pituitary adrenal function in end-stage non-alcoholic liver disease. J Gastroenterol Hepatol 1993; 8: 247-253.
9. Martins JM, Alves J, Trinca A et al. Personality, brain asymmetry, and neuroendocrine reactivity in two immune-mediated disorders: a preliminary report. Brain Behav Immunity 2002; 16: 383-397.
10. Baulieu EE, Thomas G, Legrain S et al. Dehydroepiandrosterone (DHEA), DHEA sulfate, and aging: contribution of the DHEAge Study to a sociobiomedical issue. Proc Natl Acad Sci USA 2000; 97: 4279-4284.
11. Morales AJ, Nolan JJ, Nelson JC, Yen SS. Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age. J Clin Endocrinol Metab 1994; 78: 1360-1367.
12. Piketty C, Jayle D, Leplege A et al. Double-blind placebo-controlled trial of oral dehydroepiandrosterone in patients with advanced HIV disease. Clin Endocrinol 2001; 55: 325-330.
13. Anonymous. From the Centers for Disease Control and Prevention 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. J Am Med Assoc 1993; 269: 729-730.
14. Grinspoon S, Corcoran C, Stanley T, Rabe J, Wilkie S. Mechanisms of androgen deficiency in human immunodeficiency virus-infected women with the wasting syndrome. J Clin Endocrinol Metab 2001; 86: 4120-4126.
15. Jacobson MA, Fusaro RE, Galmarini M, Lang W. Decreased serum dehydroepiandrosterone is associated with an increased progression of human immunodeficiency virus infection in men with CD4 cell counts of 200-499. J Infec Dis 1991; 164: 864-868.
16. Mulder JW, Frissen PH, Krijnen P et al. Dehydroepiandrosterone as predictor for progression to AIDS in asymptomatic human immunodeficiency virus-infected men. J Infect Dis 1992; 165: 413-418.
17. Christeff N, Melchior JC, de Truchis P, Perronne C, Nunez EA, Gougeon ML. Lipodystrophy defined by a clinical score in HIV-infected men on highly active antiretroviral therapy: correlation between dyslipidaemia and steroid hormone alterations. AIDS 1999; 13: 2251-2260.
18. Miller K, Corcoran C, Armstrong C et al. Transdermal testosterone administration in women with acquired immunodeficiency syndrome wasting: a pilot study. J Clin Endocrinol Metab 1998; 83: 2717-2725.
19. Piazza M, Tosone G, Borgia G et al. Long-term Interferon-α therapy does not affect sex hormones in males with chronic hepatitis C. J Interferon Cytokines Res 1997; 17: 525-529.
20. Christeff N, Lortholary O, Casassus P et al. Relationship between sex steroid hormone levels and CD4 lymphocytes in HIV infected men. Exp Clin Endocrinol Diabetes 1996; 104: 130-136.
21. Elekima OT, Mills CO, Ahmad A et al. Reduced hepatic content of dehydroepiandrosterone sulphotransferase in chronic liver diseases. Liver 2000; 20: 45-50.